Proposal of drug price system that allows consideration of cost-effectiveness, the promotion of development of new drugs and the elimination of drug lag

考虑成本效益、促进新药开发、消除药品滞后的药品价格制度建议

• 批准号: 22590489
• 负责人: SHIRAGAMI Makoto
• 金额: $ 2万
• 依托单位: Nihon University
• 依托单位国家: 日本
• 项目类别: Grant-in-Aid for Scientific Research (C)
• 财政年份: 2010
• 资助国家: 日本
• 起止时间: 2010 至 2012
• 项目状态: 已结题
• 来源: https://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22590489/
• 关键词: 薬価制度; 新医薬品; 新薬創出等加算; 原価計算方式; ドラッグ・ラグ; 費用対効果

We estimated the impact on the health care cost of the premium to expect the create new drugs (Sinyaku sosyutsu tou kasan) , examined the measures to offset the increase amount, showed that the drug price system in Japan is one of the causes of drug lag, made the new proposals as well as the problems of the cost accounting system, and examined the pros and cons of application of drug pricing of medical technology assessment. Based on these studies, we proposed a new drug price system which allows consideration of cost-effectiveness, promoting the development of new drugs, the elimination of drug lag as well as resulting a reasonable medical expenses.

We estimated the impact on the health care cost of the premium to expect the create new drugs (Sinyaku sosyutsu tou kasan) , examined the measures to offset the increase amount, showed that the drug price system in Japan is one of the causes of drug lag, made the new proposals as well as the problems of the cost accounting system, and examined the pros and cons of application of drug pricing of medical technology assessment.基于这些研究，我们提出了一种新的药品价格系统，该系统允许考虑成本效益，促进新药的开发，消除药物滞后以及导致合理的医疗费用。

项目成果

世界の薬価・医療制度

全球药品价格和医疗系统

• 发表时间: 2011
• 作者: 酒井文義;白神誠他
• 通讯作者: 白神誠他